Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies

被引:91
作者
Sharom, FJ [1 ]
Liu, RH [1 ]
Romsicki, Y [1 ]
Lu, PH [1 ]
机构
[1] Univ Guelph, Guelph Waterloo Ctr Grad Work Chem, Dept Chem & Biochem, Guelph, ON N1G 2W1, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 1999年 / 1461卷 / 02期
关键词
fluorescence spectroscopy; nucleotide binding; drug binding; drug transport; lipid bilayer; reconstitution;
D O I
10.1016/S0005-2736(99)00166-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The P-glycoprotein multidrug transporter is a 170-kDa efflux pump which exports a diverse group of natural products, chemotherapeutic drugs, and hydrophobic peptides across the plasma membrane, driven by ATP hydrolysis. The transporter has been proposed to interact with its drug substrates within the membrane environment; however, much remains to be learned about the nature and number of the drug binding site(s). The two nucleotide binding domains are responsible for ATP binding and hydrolysis, which is coupled to drug movement across the membrane. In recent years, P-glycoprotein has been purified and functionally reconstituted in amounts large enough to allow biophysical studies. The use of spectroscopic techniques has led to insights into both its secondary and tertiary structure, and its interaction with nucleotides and drugs. In this review, we will summarise what has been learned by application to purified P-glycoprotein of fluorescence spectroscopy, circular dichroism spectroscopy and infra-red spectroscopy. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:327 / 345
页数:19
相关论文
共 89 条
[1]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[2]   A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator [J].
Annereau, JP ;
Wulbrand, U ;
Vankeerberghen, A ;
Cuppens, H ;
Bontems, F ;
Tummler, B ;
Cassiman, JJ ;
Stoven, V .
FEBS LETTERS, 1997, 407 (03) :303-308
[3]  
BAUBICHONCORTAY H, 1994, J BIOL CHEM, V269, P22983
[4]   PLEIOTROPIC PHENOTYPE OF COLCHICINE-RESISTANT CHO CELLS - CROSS-RESISTANCE AND COLLATERAL SENSITIVITY [J].
BECHHANSEN, NT ;
TILL, JE ;
LING, V .
JOURNAL OF CELLULAR PHYSIOLOGY, 1976, 88 (01) :23-31
[5]   Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP [J].
Bolhuis, H ;
vanVeen, HW ;
Brands, JR ;
Putman, M ;
Poolman, B ;
Driessen, AJM ;
Konings, WN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) :24123-24128
[6]   Multidrug resistance in Lactococcus lactis: Evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane [J].
Bolhuis, H ;
vanVeen, HW ;
Molenaar, D ;
Poolman, B ;
Driessen, AJM ;
Konings, WN .
EMBO JOURNAL, 1996, 15 (16) :4239-4245
[7]  
BOSCH I, 1996, BIOCHIM BIOPHYS ACTA, V1288, P37
[8]   The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface [J].
Callaghan, R ;
Berridge, G ;
Ferry, DR ;
Higgins, CF .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1328 (02) :109-124
[9]   Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein [J].
Castro, AF ;
Altenberg, GA .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (01) :89-93
[10]   Diagnosis and reversal of multidrug resistance in paediatric cancers [J].
Chan, HSL ;
Grogan, TM ;
DeBoer, G ;
Haddad, G ;
Gallie, BL ;
Ling, V .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :1051-1061